Cancer Vaccines Market Trends

  • Report ID: 2402
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Cancer Vaccines Market Trends

Growth Drivers

  • Rising Cases of Cancer to Increase the Demand for Cancer Vaccines: The World Health Organization reported that cancer is the second leading cause of death globally, with around 9.6 million deaths in 2018. Around 1 in 6 deaths are as a result of cancer and about 70% of deaths from cancer take place in middle and low income countries. Moreover, it states that infections which cause cancer, such as hepatitis virus and human papilloma virus (HPV), are responsible for around 25% of cancer cases in low and middle income regions. The growing cases of cancer around the world, especially those resulting from cancer causing infections, are predicted to significantly raise the demand for cancer vaccines in the market. 
  • Side Effects of Alternate Cancer Treatment Methods to Boost the Market Growth: Existing treatments for cancer such as chemotherapy and radiotherapy are linked with certain severe side effects, including hair loss, weight loss and others. In order to avoid these, the demand for alternate treatment methods such as cancer vaccines, which are safer and highly effective, is anticipated to increase over the forecast period.

Challenges

  • High Cost of Cancer Vaccines to Hamper the Market Growth: As a result of continuous developments and entrance of improved vaccines in the market regularly, the cost of cancer vaccines is high. The increase in manufacturing expenses is high as well, which is predicted to restrict the entry of small drug manufacturers in the market. On account of high costs, people are less likely to opt for cancer vaccines as a prevention method, which is estimated to hamper the market growth in coming years.

Cancer Vaccines Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

11.6%

Base Year Market Size (2023)

USD 9.36 billion

Forecast Year Market Size (2036)

USD 38.99 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2402
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of cancer and increased demand for cancer vaccines as an alternate treatment method with lesser side effects are the major growth driving factors for the market.

The market is anticipated to attain a CAGR of 17.5% over the forecast period, i.e. 2020-2028.

The market in Asia Pacific is projected to provide more business opportunities as a result of rising cases of cancer in the region and growing presence of leading pharmaceutical and biotechnology companies.

The major players in the market are AstraZeneca, Bristol-Myers Squibb Company, GlaxoSmithKline plc., Sanofi, Merck & Co Inc, Astellas Pharma Inc., VBI Vaccines Inc., Moderna, Inc., Advaxis Immunotherapies and Galena Biopharma.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample